Tick-borne encephalitis virus vaccines
Authors:
- P. Noel BarrettPBP. Noel Barrett
- Daniel PortsmouthDPDaniel Portsmouth
- Hartmut J. EhrlichHEHartmut J. Ehrlich
Open Access
- 7 November 2012
- book chapter
- Published by Elsevier
- p. 773-788
Abstract
No abstract availableThis publication has 116 references indexed in Scilit:
- Chimeric Tick-Borne Encephalitis/Dengue Virus Is Attenuated in Ixodes scapularis Ticks and Aedes aegypti MosquitoesVector-Borne and Zoonotic Diseases, 2011
- Insertion of MicroRNA Targets into the Flavivirus Genome Alters Its Highly Neurovirulent PhenotypeJournal of Virology, 2011
- Reliable surveillance of tick-borne encephalitis in European countries is necessary to improve the quality of vaccine recommendationsVaccine, 2011
- A Functional Toll-Like Receptor 3 Gene (TLR3) May Be a Risk Factor for Tick-borne Encephalitis Virus (TBEV) InfectionThe Journal of Infectious Diseases, 2011
- Tick-Borne Encephalitis Virus Delays Interferon Induction and Hides Its Double-Stranded RNA in Intracellular Membrane VesiclesJournal of Virology, 2010
- Tick-borne encephalitis virus in ticks in Finland, Russian Karelia and BuryatiaJournal of General Virology, 2010
- The neurovirulence and neuroinvasiveness of chimeric tick-borne encephalitis/dengue virus can be attenuated by introducing defined mutations into the envelope and NS5 protein genes and the 3′ non-coding region of the genomeVirology, 2010
- Tick-borne encephalitis in the age of general mobilityWiener Medizinische Wochenschrift, 2010
- Evaluation of the Langat/dengue 4 chimeric virus as a live attenuated tick-borne encephalitis vaccine for safety and immunogenicity in healthy adult volunteersVaccine, 2008
- The envelope glycoprotein from tick-borne encephalitis virus at 2 Å resolutionNature, 1995